Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Client Area Book a 7-day Readout
Blossom logo — Medical Cannabis Products & Services

Blossom

Medical Cannabis Products & Services

Founded 2018 United Kingdom London, United Kingdom 84 employees Series A Biotechnology, Health Care

General Information

Company Name Blossom
Founded Year 2018
Location United Kingdom London, United Kingdom
Employees 84
Industries Biotechnology, Health Care
Funding Stage Series A
Business Model B2B, D2C
Revenue Model Service Fee, Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Blossom. To contact Blossom, visit blossompharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Blossom compare?

A PDF of Blossom and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Blossom soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Blossom

Blossom, a UK-based company founded in 2018, is a leader in the Biotechnology and Health Care sectors, focusing on Medical Cannabis Products & Services. Through its expertise in pharmaceutical contract manufacturing, Blossom provides a comprehensive suite of services that extends to both the production and logistics of medical cannabis products.

The company's dedication to being a foremost expert in its field reflects its strategic approach to capturing a share of the rapidly expanding medical cannabis market. With a strong foothold in the United Kingdom, Blossom is well-positioned to leverage its strategic insights and logistical capabilities to scale its operations further.

Most recently, Blossom received a crucial boost from its Series A investment on 01 April 2022, highlighting investor confidence and supporting its growth ambitions. This financial infusion provides the necessary capital for Blossom to enhance its service offerings and expand its market reach.

Business keywords: Medical Cannabis, Pharmaceutical Contract Manufacturing, Cannabis Genetics, Proprietary Products, Scientific Research, EU-GMP Compliance, Cannabis Production, Logistics Management, Cannabis Services, Advanced Medicinal Cannabis

Services & Products

EU-GMP Manufacturing
Contract Manufacturing
Storage and Distribution
Import and Export
Final Product Manufacturing
API Product Manufacturing

Target Customers

Medical Cannabis Companies Global Pharmaceutical Brands Healthcare Professionals Cannabis Product Manufacturers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed -
01 Apr 2022
Seed Round Undisclosed 1
Deepbridge Capital
Deepbridge Capital
01 Apr 2020

Blossom Alternatives & Competitors

View All Alternatives
Blossom vs
Heppe Medical Chitosan GmbH
Heppe Medical Chitosan GmbH Germany

German chitosan producer for worldwide medical technology and pharmaceutical industry.

Series B
8 employees
Biotechnology, Health Care
Compare Blossom vs Heppe Medical Chitosan GmbH
Blossom vs
The Valens Company
The Valens Company Canada

Leading manufacturer of branded cannabis products (TSX | NASDAQ: VLNS)

Post-IPO Equity
57 employees
Biotechnology, Health Care
Compare Blossom vs The Valens Company
Blossom vs
TTS Pharma Ltd
TTS Pharma Ltd United Kingdom

TTS Pharma | Advancing Innovation in Medicinal Cannabis & Wellness Solutions 🌿💡

Series B
2 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Blossom

Medical Cannabis Products & Services
Blossom was founded in 2018.
Blossom is headquartered in London, United Kingdom.
Blossom operates in Biotechnology and Health Care. Its work centres on Medical Cannabis, Pharmaceutical Contract Manufacturing, Cannabis Genetics and Proprietary Products. Its customers include Medical Cannabis Companies, Global Pharmaceutical Brands and Healthcare Professionals.
Blossom has a B2B and D2C business model. Its revenue comes from Service Fee, Product Sales and Licensing.
Blossom has approximately 84 employees.
Blossom has completed 2 funding rounds. The latest funding stage is Series A.
Blossom offers: EU-GMP Manufacturing, Contract Manufacturing, Storage and Distribution, Import and Export, Final Product Manufacturing, API Product Manufacturing.
Top alternatives and competitors to Blossom include Heppe Medical Chitosan GmbH, The Valens Company, TTS Pharma Ltd, Addis Pharmaceutical Factory, Wickham Micro Limited - A Cormica Lab. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Blossom and Heppe Medical Chitosan GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Blossom, https://bouncewatch.com/company/blossom-genetics, updated 19 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout